Your browser doesn't support javascript.
loading
Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions.
Ciciriello, Fabiana; Panariello, Francesco; Medino, Paola; Biffi, Arianna; Alghisi, Federico; Rosazza, Chiara; Annunziata, Patrizia; Bouchè, Valentina; Grimaldi, Antonio; Guidone, Daniela; Venturini, Arianna; Alicandro, Gianfranco; Oggioni, Massimo; Cerino, Pellegrino; Paiola, Giulia; Gramegna, Andrea; Fiocchi, Alessandro; Bandera, Alessandra; Lucidi, Vincenzina; Cacchiarelli, Davide; Galietta, Luis J V; Colombo, Carla.
Affiliation
  • Ciciriello F; Cystic Fibrosis Center, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy.
  • Panariello F; Telethon Institute of Genetics and Medicine (TIGEM), Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy.
  • Medino P; Pediatric Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilan, Italy.
  • Biffi A; Pediatric Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilan, Italy.
  • Alghisi F; Cystic Fibrosis Center, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy.
  • Rosazza C; Pediatric Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilan, Italy.
  • Annunziata P; Telethon Institute of Genetics and Medicine (TIGEM), Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy; NEGEDIA (Next Generation Diagnostic srl), Pozzuoli, Italy.
  • Bouchè V; Telethon Institute of Genetics and Medicine (TIGEM), Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy.
  • Grimaldi A; Telethon Institute of Genetics and Medicine (TIGEM), Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy; Department of Translational Medicine, University of Naples Federico II, Naples, Italy.
  • Guidone D; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Venturini A; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Alicandro G; Pediatric Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Oggioni M; Clinical Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milan, Italy.
  • Cerino P; Centro di Referenza Nazionale per l'analisi e studio di correlazione tra ambiente, animale e uomo. Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Italy.
  • Paiola G; Cystic Fibrosis Center, Azienda Ospedaliero Universitaria Integrata di Verona, Pl. Aristide Stefani 1 37126 Verona, Italy.
  • Gramegna A; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Fiocchi A; Cystic Fibrosis Center, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy.
  • Bandera A; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Clinic of Infectious Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Lucidi V; Cystic Fibrosis Center, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy.
  • Cacchiarelli D; Telethon Institute of Genetics and Medicine (TIGEM), Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy; Department of Translational Medicine, University of Naples Federico II, Naples, Italy; School for Advanced Studies, Genomics and Experimental Medicine Program, University of Nap
  • Galietta LJV; Department of Translational Medicine, University of Naples Federico II, Naples, Italy; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy. Electronic address: l.galietta@tigem.it.
  • Colombo C; Pediatric Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. Electronic address: carla.colombo@unimi.it.
J Cyst Fibros ; 23(4): 625-632, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38508950
ABSTRACT

BACKGROUND:

People with cystic fibrosis (pwCF) are considered at risk of developing severe forms of respiratory viral infections. We studied the consequences of COVID-19 and virus-host cell interactions in CF vs. non-CF individuals.

METHODS:

We enrolled CF and non-CF individuals, with /without COVID-like symptoms, who underwent nasopharyngeal swab for detection of SARS-CoV-2. Gene expression was evaluated by RNA sequencing on the same nasopharyngeal swabs. Criteria for COVID-19 severity were hospitalization and requirement or increased need of oxygen therapy.

RESULTS:

The study included 171 patients (65 pwCF and 106 non-CF individuals). Among them, 10 pwCF (15.4 %) and 43 people without CF (40.6 %) tested positive at RT-PCR. Symptomatic infections were observed in 8 pwCF (with 2 requiring hospitalization) and in 11 individuals without CF (6 requiring hospitalization). Host transcriptomic analysis revealed that genes involved in protein translation, particularly ribosomal components, were downregulated in CF samples irrespective of SARS-CoV-2 status. In SARS-CoV-2 negative individuals, we found a significant difference in genes involved with motile cilia expression and function, which were upregulated in CF samples. Pathway enrichment analysis indicated that interferon signaling in response to SARS-CoV-2 infection was upregulated in both pwCF and non-CF subjects.

CONCLUSIONS:

COVID-19 does not seem to be more severe in CF, possibly due to factors intrinsic to this population the lower expression of ribosomal genes may downregulate the protein translation machinery, thus creating an unfavorable environment for viral replication.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severity of Illness Index / Cystic Fibrosis / SARS-CoV-2 / COVID-19 Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Cyst Fibros Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severity of Illness Index / Cystic Fibrosis / SARS-CoV-2 / COVID-19 Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Cyst Fibros Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Netherlands